Helix TCS Expands into Global Markets

Many cannabis investors have focused their attention on North American markets, but emerging international markets could be the next frontier. Canadian licensed producers have started expanding into new export markets, consulting companies are offering their expertise, and ancillary service providers are expanding their products and services. Investors may want to take a closer look at companies that have embraced these kinds of expansion.

Helix TCS Inc. (OTCQB: HLIX) is a leading provider of ancillary services to the legal cannabis industry with over 2,000 customer locations in 33 US states and six countries around the world. With a proprietary technology suite and security service offerings, the company has processed over $18 billion in cannabis sales and helped countless businesses remain compliant with evolving government regulations.

In this article, we will take a look at some of the company’s international expansion efforts and why investors may want to take note.

Please click here to download the investor fact sheet and receive updates

Europe’s Nascent Cannabis Market

Europe has about 750 million citizens spread across 50 different countries, making it one of the largest potential cannabis markets in the world. By comparison, North America has roughly 580 million citizens spread across just 20 countries. Europe’s cannabis industry may not be as permissive as North America, but the European Parliament recently voted on a resolution that incentivizes European countries to increase access to medical cannabis.

Helix TCS recently announced an expansion into Europe via new agreements with licensed cultivators and manufacturers in the United Kingdom. These companies have started using the company’s flagship seed-to-sale tracking solution, BioTrackTHC, to track cannabis plants throughout the supply chain. The presence in the United Kingdom could be a springboard to the rest of Europe, including Germany’s rapidly growing market.

“As international markets develop and more countries create a legal cannabis industry, our technology and services solution will continue to reach new markets quickly to meet the needs of businesses and regulators in any regulatory environment,” says Helix TCS CEO Zachary L. Venegas. “We are very excited to see the progress of legal cannabis on the global stage and look forward to continuing to play a vital role.”

Please click here to download the investor fact sheet and receive updates

A Growing Presence in Australia

Australia’s cannabis industry could be worth upwards of $5.5 billion by 2023, according to Prohibition Partners, when factoring in both medical and recreational markets. In addition to already being a leading exporter of agricultural products, the country is well positioned to serve the lucrative Oceania region, which includes some of the most populous countries in the world—China, Japan, Singapore and Indonesia.

Helix TCS has already established a leadership position in the Australian and New Zealand cannabis markets. Demand for medical cannabis in both of these countries continues to rise as they lay the groundwork for safe and transparent patient access, which makes reliable and secure seed-to-sale tracking software essential to the industry’s success. BioTrackTHC’s proven track record makes it a natural choice for these seed-to-sale tracking capabilities.

“BioTrackTHC can service businesses in countries halfway around the world because of our geographically distributed team,” says BioTrackTHC Chief Operating Officer Dr. Moe Afaneh. “With support spanning more than four time zones, we are confident in our ability to support the medical cannabis operators in Australia and New Zealand as they prepare to launch and scale their businesses.”

Please click here to download the investor fact sheet and receive updates

Looking Ahead

Helix TCS Inc. (OTCQB: HLIX) is an established provider of ancillary cannabis products and services with an existing presence in 33 US states and six countries around the world. As new international markets open up, the company is well positioned to leverage its success in the most dominant global cannabis industries, ultimately creating significant barriers to competition.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.